Lord's Mark Advances AI-Based Radiation-Free Breast Cancer Screening to Final Trials
Lord's Mark Industries Limited, in collaboration with C-MET, is advancing its AI-powered, radiation-free wearable breast cancer screening technology towards final clinical trials in the USA, Great Britain, Europe, and India. Using thermal sensors and AI-driven temperature mapping, the non-invasive device aims to detect cancer at the cellular level with a target accuracy of 98%. Phase 2 trials are planned for 2027, with commercial availability contingent on regulatory approval. The technology has undergone high-accuracy testing and has attracted interest from medical device companies.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (74/100). Lens Score 47/100.
Outlets measured: moneycontrol, indiatoday. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (74–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
indiatoday broke this story on 30 Sept, 11:23 am. Other outlets followed.